𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus : Results of a multicenter randomized, double-blind, placebo-controlled trial

✍ Scribed by Michelle A. Petri; Philip J. Mease; Joan T. Merrill; Robert G. Lahita; Mark J. Iannini; David E. Yocum; Ellen M. Ginzler; Robert S. Katz; Oscar S. Gluck; Mark C. Genovese; Ronald Van Vollenhoven; Kenneth C. Kalunian; Susan Manzi; Maria W. Greenwald; Jill P. Buyon; Nancy J. Olsen; Michael H. Schiff; Arthur F. Kavanaugh; Jacques R. Caldwell; Rosalind Ramsey-Goldman; E. William St. Clair; Allan L. Goldman; Rita M. Egan; Richard P. Polisson; Kevin G. Moder; Naomi F. Rothfield; Robert T. Spencer; Kathryn Hobbs; Barri J. Fessler; Leonard H. Calabrese; Larry W. Moreland; Stanley B. Cohen; Betty J. Quarles; Vibeke Strand; Marc Gurwith; Kenneth E. Schwartz


Book ID
118282128
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
156 KB
Volume
50
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II, randomized, double-blind, pl
✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 372 KB πŸ‘ 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National